Assessing Short- and Medium-Term Outcomes of Lung Transplantation in Elderly Recipients: A Comparative Age-Based Analysis
Authors:
- Chiara CatelliCCChiara Catelli
- Andrea Lloret MadridAMAndrea Lloret Madrid
- David BennettDBDavid Bennett
- Miriana D’alessandroMiriana D’alessandro
- Marco GuerrieriMGMarco Guerrieri
- Marianna RizzoMRMarianna Rizzo
- Daniele MarianelloDMDaniele Marianello
- Antonella FossiAFAntonella Fossi
- Piero PaladiniPPPiero Paladini
- Elena BargagliElena Bargagli
- Luca LuzziLLLuca Luzzi
Open Access
- 17 September 2025
- journal article
- research article
- Published by MDPI AG in Transplantology
- Vol. 6 (3) , 28
Abstract
Background/Objectives: This study aims to analyze the short- and medium-term outcomes of lung transplantation (LT) in recipients aged 65 years and older, comparing them with those of younger individuals. The primary endpoints were 90-day and 1-year survival, while secondary measures included perioperative complications and chronic lung allograft dysfunction (CLAD) rates. Methods: A retrospective cohort analysis was conducted on 135 patients who underwent LT at the Siena Lung Transplant Center between January 2013 and December 2023. The participants were stratified into three age groups: under 60 years (Group Y), 60–65 years (Group M), and over 65 years (Group O). Outcomes assessed included ischemia times, transplant type (single or bilateral), ICU and hospital stay, postoperative complications, and CLAD incidence. The data were analyzed using non-parametric statistics, Kaplan–Meier survival curves, and correlation tests between clinical variables and survival outcomes. Results: Among the patients, 88 belonged to Group Y, 36 to Group M, and 11 to Group O. Idiopathic pulmonary fibrosis (IPF) was prevalent in older recipients (82%). Patients over 65 showed a lower prevalence of diabetes (p = 0.025) and pulmonary hypertension (p < 0.01). Bilateral LT was most common in Group Y (91%) and least in Group O (36%, p < 0.0001). Group Y had the longest maximum ischemia time (425 ± 161 min vs. 315 ± 140 min in Group O, p = 0.048). ICU stay (p = 0.289) and hospital stay (p = 0.900) did not differ significantly across groups. No group differences were observed in rates of primary graft dysfunction (p = 0.869), need for renal replacement therapy (p = 0.358), or prolonged ventilation (p = 0.609). CLAD incidence was comparable (p = 0.400), as were 90-day (p = 0.997) and 1-year survival rates (p = 0.174). Conclusions: Carefully selected patients over 65 years old can achieve similar short- and medium-term outcomes to younger LT recipients. These findings support the inclusion of older candidates in transplant programs, while highlighting the need for further research to optimize perioperative strategies and long-term management in this age group.Keywords
This publication has 25 references indexed in Scilit:
- Single vs Double Lung Transplantation in Older AdultsChest, 2024
- OPTN/SRTR 2022 Annual Data Report: LungAmerican Journal of Transplantation, 2024
- Outcomes of Lung Transplant Candidates Aged ≥70 Years During the Lung Allocation Score EraThe Annals of Thoracic Surgery, 2023
- Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung TransplantationThe Journal of Heart and Lung Transplantation, 2021
- Single- Versus Double-Lung Transplantation in Pulmonary Fibrosis: Impact of Age and Pulmonary HypertensionThe Annals of Thoracic Surgery, 2018
- Pretransplant frailty is associated with decreased survival after lung transplantationThe Journal of Heart and Lung Transplantation, 2016
- What Is the Optimal Transplant for Older Patients With Idiopathic Pulmonary Fibrosis?The Annals of Thoracic Surgery, 2015
- Is There an Age Limit to Lung Transplantation?The Annals of Thoracic Surgery, 2015
- Contemporary analysis of early outcomes after lung transplantation in the elderly using a national registryThe Journal of Heart and Lung Transplantation, 2015
- International Guidelines for the Selection of Lung Transplant Candidates: 2006 Update—A Consensus Report From the Pulmonary Scientific Council of the International Society for Heart and Lung TransplantationThe Journal of Heart and Lung Transplantation, 2006